Collaboration with the University of Queensland, Zucero Therapeutics, Institutions such as the University of Liverpool (UK), Keele University (UK), Public Health England (UK) and the University of Gothenburg (Sweden) led to the investigation of pixatimod against COVID19 (https://www.news-medical.net/news/20200625/Pixatimod-is-active-in-lab-studies-against-SARS-CoV-2.aspx ). Also received the Front cover of ACS Central Science, 2022.

Check my interview https://theinterviewportal.com/2022/06/14/structural-biologist-interview-3/

One of our works (2021) on simulations and experiments CoV-2 spike proteins gained attention in QUT media, Brisbane times (https://www.brisbanetimes.com.au/national/queensland/chemical-octopus-could-be-key-to-battling-covid-variants-20210706-p587cb.html), WA Today, Australian Internet, The Age & Sydney Morning Herald and Medscape (https://www.medscape.com/viewarticle/955147).

Work on Tau proteins received attention on the Pawsey High-performance computing website (https://pawsey.org.au/case_studies/combating-alzheimers-and-dementia/ ).